Elliott B. Grossbard is Sr. VP Medical Development at RIGEL PHARMACEUTICALS INC (RIGL). They have made 1 open-market trade across 1 company since 2007, most recently 2007-05-29.
CIK 0001190277
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $19K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RIGL | 2,000 | $92K |
Shares reported on the most recent Form 4, priced at the 2007-05-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RIGL | BUY | 2007-05-29 | 2007-05-29 | $9.68 | $19K | -8.6% | -5.6% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.